Document is current
Any future updates will be listed below
-
Authors
Kim, Ji Yoon
Sulis, Giorgia
Russell, Alton
Yang, Seungmi
Papenburg, Jesse
Banerjee, Ananya
Li, Patricia
-
Funding
Funding for this research was provided by:
McGill University
Canadian Institutes of Health Research (480056)
Institut universitaire SHERPA
Canada Research Chairs
Fonds de Recherche du Québec - Santé
- License Information
-
More Information
Article History
Received: 8 January 2025
Accepted: 19 September 2025
First Online: 4 November 2025
Declarations
:
: The CLSA study has been approved by McMaster University Health Integrated Research Ethics Board and by research ethics boards at all collaborating institutions. All participants of the CLSA provided informed written consent during data collection. As this study is a secondary analysis of fully de-identified data provided by the CLSA, additional consent was not required. Ethics approval for the current study was obtained from the McGill University Institutional Research Board (A04-M19-23A (23–04-012)). All study procedures were performed in accordance with the Declaration of Helsinki.
: Not applicable.
: JP reports personal fees from Enanta and participation in clinical trials funded by Merck and MedImmune.
